These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 7544327)

  • 21. [Possibility and reality, with or without responsibility. (The prevention of neural tube defects)].
    Orv Hetil; 1988 Sep; 129(38):2059. PubMed ID: 3174133
    [No Abstract]   [Full Text] [Related]  

  • 22. [Success in informing pregnant women concerning blood alpha fetoprotein determination for the detection of neural tube defects in the fetus].
    Tijmstra T; Huisjes HJ
    Ned Tijdschr Geneeskd; 1983 Mar; 127(13):541-5. PubMed ID: 6188959
    [No Abstract]   [Full Text] [Related]  

  • 23. At increased risk: neural tube defect relatives.
    Hecht F; Hecht BK; Wagner RC; Szucs SC
    Ariz Med; 1983 Nov; 40(11):759-62. PubMed ID: 6197956
    [No Abstract]   [Full Text] [Related]  

  • 24. [The triple-serum test for detection of Down syndrome and neural tube defects; the problem of a risk assessment test].
    van den Boer-van den Berg JM; Dupuis HM
    Ned Tijdschr Geneeskd; 1993 Jun; 137(26):1286-9. PubMed ID: 7688445
    [No Abstract]   [Full Text] [Related]  

  • 25. Screening and diagnosis of fetal neural tube defects, abdominal wall defects and Down's syndrome. With special reference to biochemical and ultrasound screening in the second trimester of pregnancy and to early amniocentesis.
    Jørgensen FS
    Dan Med Bull; 2001 Aug; 48(3):127-45. PubMed ID: 11556264
    [No Abstract]   [Full Text] [Related]  

  • 26. Prenatal testing.
    Marmion P
    Am Fam Physician; 1987 Oct; 36(4):51-8. PubMed ID: 2445191
    [No Abstract]   [Full Text] [Related]  

  • 27. Informed consent: providing information about prenatal examinations.
    Dahl K; Kesmodel U; Hvidman L; Olesen F
    Acta Obstet Gynecol Scand; 2006; 85(12):1420-5. PubMed ID: 17260215
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Serum alpha-feto protein screening for neural tube defects: some notes for programme evaluators.
    Mason ES; Clarke M
    J R Soc Health; 1986 Dec; 106(6):210-2. PubMed ID: 2433441
    [No Abstract]   [Full Text] [Related]  

  • 29. Antenatal screening for neural tube defects.
    Smith L
    Mod Midwife; 1995 Jul; 5(7):27-9. PubMed ID: 7542147
    [No Abstract]   [Full Text] [Related]  

  • 30. [Defects in neural tube closure in the Vaud canton 1980-1992. The impact of prenatal diagnosis].
    Marguerat P; Addor MC; Pescia G; Maillard-Brignon C; Laurini RN; Hohlfeld P; Vial Y; Weihs D
    Rev Med Suisse Romande; 1994 Oct; 114(10):851-9. PubMed ID: 7526434
    [No Abstract]   [Full Text] [Related]  

  • 31. Using automated prenatal screening assays in the clinical laboratory.
    Blacklaw M
    Am Clin Lab; 2000; 19(1):14. PubMed ID: 10848433
    [No Abstract]   [Full Text] [Related]  

  • 32. Ethics and prenatal testing.
    Jackson R
    Am Fam Physician; 1987 Aug; 36(2):49. PubMed ID: 2441584
    [No Abstract]   [Full Text] [Related]  

  • 33. AFP-screening for all?
    Davies DP; Cole GF; Derbyshire F; Jones AJ
    Lancet; 1980 May; 1(8179):1195. PubMed ID: 6155577
    [No Abstract]   [Full Text] [Related]  

  • 34. Women's attitudes toward the serum alpha-fetoprotein test.
    Dembert ML; Watson RE; Mick SS; Phillips R; Meyer J; Matzkin P; Harisiades JP; Mahoney MJ
    Conn Med; 1983 Sep; 47(9):525-9. PubMed ID: 6194933
    [No Abstract]   [Full Text] [Related]  

  • 35. Isolating fetal cells in maternal blood -- the importance of ethical reflection.
    NABER Rep; 1996; 2(1):1-2, 5. PubMed ID: 11654380
    [No Abstract]   [Full Text] [Related]  

  • 36. Alpha-fetoprotein screening.
    Crandall BF
    West J Med; 1984 Jun; 140(6):931. PubMed ID: 6204461
    [No Abstract]   [Full Text] [Related]  

  • 37. [Multiple of the median and its uses in antenatal screening].
    Jiangsu Province Birth Planning Commitee
    Zhonghua Fu Chan Ke Za Zhi; 2004 Jun; 39(6):428-9. PubMed ID: 15312334
    [No Abstract]   [Full Text] [Related]  

  • 38. Neural tube defects/alpha-fetoprotein/Down's syndrome screening.
    Aitken DA; Crossley JA
    Curr Opin Obstet Gynecol; 1997 Apr; 9(2):113-20. PubMed ID: 9204233
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Benefits of maternal serum alpha-fetoprotein testing.
    Dyson RD
    Am Fam Physician; 1996 Nov; 54(6):1890, 1893. PubMed ID: 8900347
    [No Abstract]   [Full Text] [Related]  

  • 40. Prenatal screening for neural tube defects.
    Rajesh R; Thomas SV
    Natl Med J India; 2001; 14(6):343-6. PubMed ID: 11804365
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.